Verma, R., Mohl, D. & Deshaies, R. J. Harnessing the power of proteolysis for targeted protein inactivation. Mol. Cell 77, 446–460 (2020).

Article  CAS  PubMed  Google Scholar 

Burslem, G. M. & Crews, C. M. Proteolysis-targeting chimeras as therapeutics and tools for biological discovery. Cell 181, 102–114 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nalawansha, D. A. & Crews, C. M. PROTACs: an emerging therapeutic modality in precision medicine. Cell Chem. Biol. 27, 998–1014 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mayor-Ruiz, C. et al. Plasticity of the cullin-RING ligase repertoire shapes sensitivity to ligand-induced protein degradation. Mol. Cell 75, 849–858 (2019).

Article  CAS  PubMed  Google Scholar 

Lu, G. et al. UBE2G1 governs the destruction of cereblon neomorphic substrates. eLife 7, e40958 (2018).

Hill, S. et al. Robust cullin-RING ligase function is established by a multiplicity of poly-ubiquitylation pathways. eLife 8, e51163 (2019).

Bekes, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181–200 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jan, M., Sperling, A. S. & Ebert, B. L. Cancer therapies based on targeted protein degradation—lessons learned with lenalidomide. Nat. Rev. Clin. Oncol. 18, 401–417 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Wang, Y., Jiang, X., Feng, F., Liu, W. & Sun, H. Degradation of proteins by PROTACs and other strategies. Acta Pharm. Sin. B 10, 207–238 (2020).

Article  CAS  PubMed  Google Scholar 

Alabi, S. B. & Crews, C. M. Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs. J. Biol. Chem. 296, 100647 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pohl, C. & Dikic, I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science 366, 818–822 (2019).

Article  CAS  PubMed  Google Scholar 

Swatek, K. N. & Komander, D. Ubiquitin modifications. Cell Res. 26, 399–422 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haakonsen, D. L. & Rape, M. Branching out: improved signaling by heterotypic ubiquitin chains. Trends Cell Biol. 29, 704–716 (2019).

Article  CAS  PubMed  Google Scholar 

Ye, Y. & Rape, M. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 10, 755–764 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gadd, M. S. et al. Structural basis of PROTAC cooperative recognition for selective protein degradation. Nat. Chem. Biol. 13, 514–521 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaiho-Soma, A. et al. TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains. Mol. Cell 81, 1411–1424 (2021).

Article  CAS  PubMed  Google Scholar 

Peltzer, N., Darding, M. & Walczak, H. Holding RIPK1 on the ubiquitin leash in TNFR1 signaling. Trends Cell Biol. 26, 445–461 (2016).

Article  CAS  PubMed  Google Scholar 

Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131, 669–681 (2007).

Article  CAS  PubMed  Google Scholar 

Cong, H. et al. Inhibitor of apoptosis protein (IAP) antagonists in anticancer agent discovery: current status and perspectives. J. Med. Chem. 62, 5750–5772 (2019).

Article  CAS  PubMed  Google Scholar 

Ohoka, N. et al. In vivo knockdown of pathogenic proteins via specific and nongenetic inhibitor of apoptosis protein (IAP)-dependent protein erasers (SNIPERs). J. Biol. Chem. 292, 4556–4570 (2017).

Tsuchiya, H. et al. In vivo ubiquitin linkage-type analysis reveals that the Cdc48-Rad23/Dsk2 axis contributes to K48-linked chain specificity of the proteasome. Mol. Cell 66, 488–502 (2017).

Article  CAS  PubMed  Google Scholar 

Xu, M., Skaug, B., Zeng, W. & Chen, Z. J. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFα and IL-1β. Mol. Cell 36, 302–314 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat. Cell Biol. 11, 123–132 (2009).

Article  CAS  PubMed  Google Scholar 

Bertrand, M. J. et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689–700 (2008).

Article  CAS  PubMed  Google Scholar 

Park, S. M., Yoon, J. B. & Lee, T. H. Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro. FEBS Lett. 566, 151–156 (2004).

Article  CAS  PubMed  Google Scholar 

Hospenthal, M. K., Mevissen, T. E. & Komander, D. Deubiquitinase-based analysis of ubiquitin chain architecture using Ubiquitin Chain Restriction (UbiCRest). Nat. Protoc. 10, 349–361 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Michel, M. A. et al. Assembly and specific recognition of K29- and K33-linked polyubiquitin. Mol. Cell 58, 95–109 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ohtake, F., Saeki, Y., Ishido, S., Kanno, J. & Tanaka, K. The K48-K63 branched ubiquitin chain regulates NF-κB signaling. Mol. Cell 64, 251–266 (2016).

Article  CAS  PubMed  Google Scholar 

Swatek, K. N. et al. Insights into ubiquitin chain architecture using Ub-clipping. Nature 572, 533–537 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deol, K. K. et al. Proteasome-bound UCH37/UCHL5 debranches ubiquitin chains to promote degradation. Mol. Cell 80, 796–809 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eddins, M. J., Carlile, C. M., Gomez, K. M., Pickart, C. M. & Wolberger, C. Mms2-Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation. Nat. Struct. Mol. Biol. 13, 915–920 (2006).

Article  CAS  PubMed  Google Scholar 

Ohtake, F. et al. Ubiquitin acetylation inhibits polyubiquitin chain elongation. EMBO Rep. 16, 192–201 (2015).

Article  CAS  PubMed  Google Scholar 

Yau, R. G. et al. Assembly and function of heterotypic ubiquitin chains in cell-cycle and protein quality control. Cell 171, 918–933 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naito, M., Ohoka, N., Shibata, N. & Tsukumo, Y. Targeted protein degradation by chimeric small molecules, PROTACs and SNIPERs. Front. Chem. 7, 849 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schiemer, J. et al. Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes. Nat. Chem. Biol. 17, 152–160 (2021).

Article  CAS  PubMed  Google Scholar 

Fulda, S. & Vucic, D. Targeting IAP proteins for therapeutic intervention in cancer. Nat. Rev. Drug Discov. 11, 109–124 (2012).

Article  CAS  PubMed  Google Scholar 

Wu, X. et al. Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade. Proc. Natl Acad. Sci. USA 111, 13870–13875 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Komander, D. & Rape, M. The ubiquitin code. Annu. Rev. Biochem. 81, 203–229 (2012).

Article  CAS  PubMed  Google Scholar 

Ohtake, F., Tsuchiya, H., Saeki, Y. & Tanaka, K. K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains. Proc. Natl Acad. Sci. USA 115, E1401–E1408 (2018).

Article